VETSORB PGA 2-0 TAPER POINT PK12S 26MM
Guaranteed safe payment
VETSORB PGA 2‑0 TAPER POINT PK12S 26MM
The VETSORB PGA 2‑0 Taper Point PK12S 26 mm surgical suture is a product for veterinary use made from polyglycolic acid (PGA), an absorbable synthetic material. The suture is braided and coated with a blend of polycaprolactone and calcium stearate to enhance its smoothness within tissues and reduce friction. It is also dyed purple with D&C Violet No. 2 for easy visibility during procedures. Absorption begins with a gradual loss of tensile strength, followed by mass loss, and is usually complete within 75 to 90 days post-implantation.
Absorbable synthetic material for veterinary use
Coated for easy handling and reduced tissue friction
Low tissue reaction and limited capillarity
Excellent tensile strength retention during the early wound healing phase
Purple dye enhances visibility during placement
Braided polyglycolic acid (100%) suture
Coating: Polycaprolactone and calcium stearate
Dyed with D&C Violet No. 2
Intended for the approximation and ligation of general soft tissues in veterinary surgery, including muscles, aponeuroses, and ophthalmic surgery. Not intended for use in cardiovascular or neurological tissues. Used with a taper point needle in the standard surgical manner. Dosage and method of use should be determined by a qualified veterinarian based on the animal type, weight, and clinical condition.
Box containing 12 sutures (PK12S), each equipped with a 26 mm needle.
Absorption profile: Retains about 80% of tensile strength after 14 days; loses 90% of strength by the end of the fourth week; minimal mass absorption after two weeks, about 25% after 4 weeks, about 75% after two months, and nearly complete between 75–90 days.
The VETSORB PGA 2‑0 Taper Point PK12S 26 mm surgical suture is a product for veterinary use made from polyglycolic acid (PGA), an absorbable synthetic material. The suture is braided and coated with a blend of polycaprolactone and calcium stearate to enhance its smoothness within tissues and reduce friction. It is also dyed purple with D&C Violet No. 2 for easy visibility during procedures. Absorption begins with a gradual loss of tensile strength, followed by mass loss, and is usually complete within 75 to 90 days post-implantation.
Main Benefits
Absorbable synthetic material for veterinary use
Coated for easy handling and reduced tissue friction
Low tissue reaction and limited capillarity
Excellent tensile strength retention during the early wound healing phase
Purple dye enhances visibility during placement
Composition
Braided polyglycolic acid (100%) suture
Coating: Polycaprolactone and calcium stearate
Dyed with D&C Violet No. 2
Instructions for Use
Intended for the approximation and ligation of general soft tissues in veterinary surgery, including muscles, aponeuroses, and ophthalmic surgery. Not intended for use in cardiovascular or neurological tissues. Used with a taper point needle in the standard surgical manner. Dosage and method of use should be determined by a qualified veterinarian based on the animal type, weight, and clinical condition.
Package Size
Box containing 12 sutures (PK12S), each equipped with a 26 mm needle.
Note
Absorption profile: Retains about 80% of tensile strength after 14 days; loses 90% of strength by the end of the fourth week; minimal mass absorption after two weeks, about 25% after 4 weeks, about 75% after two months, and nearly complete between 75–90 days.